Abstract
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have